Cue Health’s Molecular Mpox Test Gets FDA EUA
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Emerging & Zoonotic Diseases |
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Miscellaneous |
A new survey found that patients overwhelmingly support receiving test results immediately, even if their provider has yet to review them.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Company News, Lab Automation |
INTEGRA Biosciences acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for NGS protocols.
Read MorePosted by Andy Lundin | Mar 15, 2023 | Cancer, Company News, Digital Pathology |
Proscia announced that Spectrum Healthcare Partners (SHCP) has selected Concentriq Dx to modernize its pathology operations.
Read MorePosted by Andy Lundin | Mar 14, 2023 | Sexually Transmitted Diseases |
Visby Medical has received 510(k) clearance and was granted a CLIA waiver from the FDA for its second-generation POC sexual health test.
Read More